| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC2584 |
| Trial ID | NCT04735471 |
| Disease | Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma | Primary Mediastinal B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Marginal Zone Lymphoma | Follicular Lymphoma |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ADI-001 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Safety and Efficacy Study of ADI-001, an Anti-CD20 Allogeneic Gamma Delta CAR-T, in Subjects With B Cell Malignancies |
| Year | 2021 |
| Country | United States |
| Company sponsor | Adicet Bio, Inc |
| Other ID(s) | ADI-20200101 |
| Cohort 1 | |||||||||
|
|||||||||